Profil Financier
Lam Kong occupe actuellement le rang #1905 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.2 B (-$300 sur 24h).
Lam Kong chairs Hong Kong-listed China Medical System, which distributes drugs to thousands of hospitals around the country.
Lam founded the company in 1995, almost a decade after graduating from Zhanjiang Medical College.
China Medical went public on the Hong Kong Stock Exchange in 2010.
China Medical System is the largest shareholder of Shanghai-listed Tibet Rhodiola Pharmaceutical.
China Medical System is headquartered in Shenzhen.